LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.41 | 27.76 | 146 | 3105 | 0.0470 | 0.2762 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.41 | 27.76 | 1359 | 3105 | 0.4376 | 0.7713 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.11 | 27.76 | 860 | 3331 | 0.2581 | 0.6439 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.11 | 27.76 | 874 | 3331 | 0.2623 | 0.6478 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.11 | 27.76 | 160 | 3331 | 0.0480 | 0.2887 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 41.11 | 27.76 | 1335 | 3331 | 0.4007 | 0.7520 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 42.81 | 27.76 | 851 | 3596 | 0.2366 | 0.6287 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 42.81 | 27.76 | 858 | 3596 | 0.2386 | 0.6306 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 42.81 | 27.76 | 167 | 3596 | 0.0464 | 0.2914 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 42.81 | 27.76 | 1374 | 3596 | 0.3821 | 0.7437 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 44.52 | 27.76 | 891 | 3884 | 0.2294 | 0.6268 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 44.52 | 27.76 | 904 | 3884 | 0.2327 | 0.6301 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 44.52 | 27.76 | 177 | 3884 | 0.0456 | 0.2968 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 44.52 | 27.76 | 1382 | 3884 | 0.3558 | 0.7301 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 46.22 | 27.76 | 919 | 4125 | 0.2228 | 0.6243 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 46.22 | 27.76 | 927 | 4125 | 0.2247 | 0.6262 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 46.22 | 27.76 | 175 | 4125 | 0.0424 | 0.2907 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 46.22 | 27.76 | 1409 | 4125 | 0.3416 | 0.7234 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.93 | 27.76 | 923 | 4421 | 0.2088 | 0.6145 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.93 | 27.76 | 936 | 4421 | 0.2117 | 0.6176 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.93 | 27.76 | 181 | 4421 | 0.0409 | 0.2921 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.93 | 27.76 | 1416 | 4421 | 0.3203 | 0.7117 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.63 | 27.76 | 933 | 4818 | 0.1937 | 0.6040 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.63 | 27.76 | 948 | 4818 | 0.1968 | 0.6074 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.63 | 27.76 | 200 | 4818 | 0.0415 | 0.3040 | MN20160318_Q01 | L22 |